Fernando Arribas-rekin lankidetzan egindako argitalpenak (6)

2023

  1. Bayesian analysis of the Substrate Ablation vs. Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia trial

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 25, Núm. 7

2022

  1. Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia

    Journal of the American College of Cardiology, Vol. 79, Núm. 15, pp. 1441-1453

2020

  1. The p.P888L SAP97 polymorphism increases the transient outward current (Ito,f) and abbreviates the action potential duration and the QT interval

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Diagnostic yield of the implantable loop recorder in octogenarians

    European Geriatric Medicine, Vol. 10, Núm. 1, pp. 129-133

2014

  1. Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: A multicentre, randomized, controlled trial (SARA study)

    European Heart Journal, Vol. 35, Núm. 8, pp. 501-507

  2. Comparison of radiofrequency catheter ablation of drivers and circumferential pulmonary vein isolation in atrial fibrillation: A noninferiority randomized multicenter RADAR-AF trial

    Journal of the American College of Cardiology, Vol. 64, Núm. 23, pp. 2455-2467